ReviewClinical rheumatology2026
VEXAS syndrome presenting with features of Sjögren's disease: a case-based review of VEXAS and autoimmune disease overlap.
Review in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic syndrome) is an adult-onset autoinflammatory disorder caused by somatic mutations in the UBA1 gene. While its clinical spectrum is expanding, the overlap with autoimmune diseases remains poorly characterized. We present the first reported case of VEXAS featuring overlap with Sjögren's disease. An 86-year-old man with myelodysplastic syndrome developed recurrent fevers, a skin rash, chondritis, bilateral anterior uveitis, acute kidney injury, and macrocytic anemia. He had chronic xerostomia, high titer SSA antibodies, and a positive rheumatoid factor, suggestive of Sjögren's disease. Genetic testing confirmed a UBA1 p.Met41Thr mutation. Our literature review revealed VEXAS co-occurring with various autoimmune conditions, including vasculitides, systemic lupus erythematosus, rheumatoid arthritis, spondyloarthritis, myositis, and autoimmune blistering diseases. Sjögren's disease has not previously been associated with VEXAS. This report adds to the growing evidence of VEXAS-associated autoimmunity. Recognition of such overlap may influence early diagnostic consideration and genetic testing in elderly patients with autoimmune features and cytopenias. Further studies are needed to discern whether these autoimmune features represent independent disease processes or manifestations of VEXAS itself.
Indexed as
Identifiers
41193889What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.